Free shipping on all orders over $ 500

Fosbretabulin disodium

Cat. No. M2274

All AbMole products are for research use only, cannot be used for human consumption.

Fosbretabulin disodium Structure
Synonym:

Combretastatin A-4 phosphate, CA4P

Size Price Availability Quantity
5mg USD 88  USD88 In stock
10mg USD 120  USD120 In stock
25mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Fosbretabulin disodium (Combretastatin A-4 phosphate) is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM. Fosbretabulin disodium inhibits the polymerization of tubulin with IC50 of 2.4 μM, and it also disrupts tumor vasculature. Analyses of cell-cycle distribution showed CA-4 obviously induced G(2)-M phase arrest with sub-G(1) formation. The analyses of apoptosis showed that CA-4 induced caspase-3 activation and decreased BubR1 and Bub3 in cancer cells. Fosbretabulin disodium increases endothelial cell permeability, while inhibiting endothelial cell migration and capillary tube formation predominantly through disruption of VE-cadherin/β-catenin/Akt signaling pathway, thereby leading to rapid vascular collapse and tumor necrosis. Combretastatin A-4 phosphate (fosbretabulin disodium) is a microtubule destabilizing drug, a type of vascular-targeting agent, a compound designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.

Chemical Information
Molecular Weight 440.29
Formula C18H19Na2O8P
CAS Number 168555-66-6
Solubility (25°C) Water 25 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhang C, et al. Oncol Rep. Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo.

[2] Shen CH, et al. Br J Pharmacol. Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

[3] Mooney CJ, et al. Thyroid. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.

Related Microtubule Products
CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

Paclitaxel-d5

Paclitaxel-d5

  Catalog
Abmole Inhibitor Catalog




Keywords: Fosbretabulin disodium, Combretastatin A-4 phosphate, CA4P supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.